Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens

M Savvas,J W Studd,S Norman,A T Leather,T J Garnett,I Fogelman
DOI: https://doi.org/10.1111/j.1471-0528.1992.tb13879.x
Abstract:Objective: To determine the effect on the bone density of the skeleton after changing from oral oestrogen to subcutaneous oestradiol and testosterone replacement. Design: Prospective non-randomized single centre study. Subjects: Twenty women who were receiving long-term oral oestrogen replacement. Ten changed to oestradiol and testosterone implants; the remaining ten continued with oral oestrogens. Main outcome measures: Bone density was measured using dual photon absorptiometry at the lumbar spine and neck of femur at the start of the study and after one year. Results: The bone density increased significantly by 5.7% at the spine and by 5.2% at the neck of femur in those women who changed to implant therapy but remained unchanged in those women who continued with oral therapy. Conclusion: Subcutaneous oestradiol and testosterone implants will result in an increase in bone mass even after many years of oral oestrogen replacement therapy.
What problem does this paper attempt to address?